  World News (12)
  World Business (847)
 USA (336)
 California (187)
 Bay Area (12)
Bay Area Business (1699)
 Peninsula (1080)
Central San Mateo County (175)
Foster City (65)
  Gilead (13)
 2017 (1)
2016 (1)
2015 (2)
2014 (2)
2011 (1)
2009 (3)
2003 (1)
2002 (2)
 Foster City Gilead on Wikipedia
 Foster City Gilead on Web
|
|
|
| Feb.7 |
|
Gilead beats Street 4Q forecasts| Gilead Sciences Inc. (GILD) on Tuesday reported fourth-quarter earnings of $3.11 billion. It had profit of $2.34 per share | |
|
|
| Feb.2 |
|
Gilead Sciences beats estimates for 4th-quarter earnings| 34 percent increase in profit, trouncing expectations, as sales of its blockbuster hepatitis C drugs soared in Japan and offset lower sales in the U.S | |
|
|
| Oct.27 |
|
Gilead Sciences beats Street 3Q forecasts Propelled by sales of hepatitis C pills, Gilead posted an impressive 68% increase in third-quarter profit and hiked its revenue forecast yet again
|
| Jul.28 |
|
Gilead profit beats Wall Street forecasts| Blockbuster hepatitis C medicine Harvoni lifted Gilead Sciences’ second-quarter profit by 23% as total revenue for the biotech drugmaker jumped 26% | |
|
|
| Mar.3 |
|
Gilead Sciences CEO joins billionaires' ranks John Martin is $1.2 billion, based on his stake in the company, which recently released a potential blockbuster drug to treat Hepatitis C
|
| Feb.5 |
|
Gilead profit beats estimates Gilead Sciences Inc., the world's largest maker of HIV medicines, has reported net income in the fourth quarter rose 3.8 percent to $791.4 million
|
|
| Nov.21 |
|
Gilead to buy Pharmasset for $11 billion| Gilead Sciences Inc. has agreed to pay about $11 billion for drug developer Pharmasset Inc. in a huge bet on experimental hepatitis C treatments | |
|
|
| Apr.28 |
 |
Flu's bad news but shot in arm for Gilead Gilead Sciences climbed nearly 4 percent to close at $47.53; they're collecting on Tamiflu, the influenza drug the biotech company invented
|
| Apr.22 |
|
Lawsuit Vs. Gilead To Proceed The U.S. Supreme Court has refused to halt a securities-fraud suit by investors who claim the biotech company inflated its stock price in 2003
|
| Mar.12 |
|
Gilead To Buy CV Therapeutics For $1.4 B| Biotechnology company Gilead Sciences, known for its HIV drugs, said it will pay $20 per share in cash for Palo Alto-based CV Therapeutics | |
|
|
| Apr.4 |
|
Company ships AIDS drug to Africa Gilead Sciences has begun shipping its new drug at cost to poor countries in Africa and other regions
|
|
| Dec.17 |
|
Gilead to slash AIDS drug price in Africa Gilead Sciences would dramatically slash the price it charges for Viread in all of Africa and 15 other least-developed countries
|
| Dec.4 |
|
Gilead buys AIDS-fighting competitor Gilead Sciences would acquire Triangle Pharmaceuticals for $464 million in cash
|
|
Add a favorite (file a bookmark) to Foster City, Gilead Timeline
Please send feedback to: support@mapreport.com
Advertise on Foster City, Gilead Page
XML
|
Gilead (13)